Lupin gets Form 483 for Pune's biotech facility
The inspection concluded with the issuance of Form 483 with seventeen observations
Lupin Pharma | 21/10/2022 | By Sudeep Soparkar | 404
Lupin launches Ethacrynic Acid Tablets USP
Pharma major Lupin Limited (Lupin) announced the launch of Ethacrynic Acid Tablets USP, 25 mg, having received approval from the United States Food and Drug Administration (U.S. FDA) earlier. The product would be manufactured at Lupin's Nagpur OSD facility, India
Lupin Pharma | 14/03/2020 | By Darshana | 631
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy